Back to Search
Start Over
Looking for peptides from rice starch processing by-product: Bioreactor production, anti-tyrosinase and anti-inflammatory activity, and in silico putative taste assessment.
- Source :
-
Frontiers in plant science [Front Plant Sci] 2022 Jul 15; Vol. 13, pp. 929918. Date of Electronic Publication: 2022 Jul 15 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- One of the major challenges for the modern society, is the development of a sustainable economy also aiming at the valorization of agro-industrial by-products in conjunction with at a significant reduction of generated residues from farm to retail. In this context, the present study demonstrates a biotechnological approach to yield bioactive peptides from a protein fraction obtained as a by-product of the rice starch production. Enzymatic hydrolysis, with the commercial proteases Alcalase and Protamex, were optimized in bioreactor up to 2 L of volume. The two best digestates, selected with respect to peptide release and extract antioxidant capacity, were further fractionated (cut-offs of 10, 5, and 1 kDa) via cross-flow filtration. Amino acid composition indicated that most of the fractions showed positive nutritional characteristics, but a putative bitter taste. A fraction obtained with Alcalase enzyme (retentate 8 kDa) exerted anti-inflammatory potential, while the smaller molecular weight fractions (retentate 1-5 kDa and permeate < 1 kDa) were more active in tyrosinase inhibition. The latter were further sub-fractionated by size-exclusion chromatography. From the 15 most anti-tyrosinase sub-fractions, 365 peptide sequences were identified via liquid chromatography coupled with high resolution mass spectrometry. The present data support the possible exploitation of bioactive peptide from rice starch by-product as ingredients into food, nutraceutical, pharmaceutical, and cosmetic formulations.<br />Competing Interests: ML was employed by Carminia snc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Ferri, Tedeschi, Prandi, Michelini, Calabretta, Babini, Graen-Heedfeld, Bretz, Raddadi, Gianotti, Lamborghini and Tassoni.)
Details
- Language :
- English
- ISSN :
- 1664-462X
- Volume :
- 13
- Database :
- MEDLINE
- Journal :
- Frontiers in plant science
- Publication Type :
- Academic Journal
- Accession number :
- 35909767
- Full Text :
- https://doi.org/10.3389/fpls.2022.929918